ACAlison V. Crum

Alison V. Crum

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alison V. Crum has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Use of a Virtual Reality Visual Field Device to Improve Quality of Care in the Emergency Department and Inpatient Setting

    by Aileen G. MacLachlan, Cameron M. Carpenter, Natalie K. Modersitzki, Alison V. Crum, Kathleen B. Digre, Bradley J. Katz, Sravanthi Vegunta, Judith E. A. Warner, Theresa M. Long, Meagan D. Seay

    Background: Automated visual field testing is an essential diagnostic and disease monitoring tool for many neuro-ophthalmic disorders. Most commonly, automated devices are stationary and located in ophthalmology clinics. Thus, formal visual field testing has been limited in the hospital setting until recent availability of virtual reality visual field testing. In this study, we report our experience with the use of a virtual visual field (VVF) device in the Emergency Department (ED) and inpatient hospital settings. Methods: We performed a retrospective chart review of our use of a VVF device in the ED and inpatient hospital setting from February 2020 to September 2022. We report our experience and the impact on patient care with use of the VVF device. Results: One hundred fifty patients (aged 10–85 years) and 162 visual field encounters were identified. Patients were most commonly located on the regular hospital ward (51%), followed by the intensive care unit (28%), and ED (21%). The VVF prevented the need for a trip to the outpatient ophthalmology clinic in 100% of encounters of patients with vision-threatening papilledema. Use of the VVF provided a more detailed, baseline examination at bedside in 61% of all encounters. A bedside pre- and postoperative visual field assessment was achieved in 14% of encounters. The VVF changed management in 70% of encounters. Conclusions: In our experience, use of the VVF has improved the quality of care for inpatients with neuro-ophthalmic conditions. A significant impact of the VVF was increased safety by preventing the need to transport patients to the outpatient setting for visual field monitoring, especially patients with vision-threatening papilledema and lumbar drains. The VVF made formal visual testing available to patients with mobility restrictions and patients undergoing neurosurgical procedures. Owing to improvement in quality of patient care, the VVF analyzer has become a mainstay of the examination of patients in the ED and hospital.

  • Congenital Ptosis

    by Alison V. Crum, Rebekah H. Gensure

  • Ocular Cicatricial Pemphigoid

    by Sravanthi Vegunta, Alison V. Crum

  • Open Access

    Increased prevalence of depression and anxiety in patients with migraine and interictal photophobia

    by Stephanie M. Llop, Jonathan E. Frandsen, Kathleen B. Digre, Bradley J. Katz, Alison V. Crum, Chong Zhang, Judith E. A. Warner

    Most patients with migraine report photophobia associated with headache; a subset report interictal photophobia. These patients are light sensitive even during headache-free periods. The objective of this case–control study was to assess the prevalence of symptoms of anxiety and depression in migraine patients with and without interictal photophobia. We recruited 16 subjects with migraine and interictal photophobia, 16 age- and gender-matched migraine subjects without interictal photophobia, and 16 age- and gender- matched controls. Migraine subjects met International Headache Society classification criteria. Participants completed a photophobia questionnaire, Beck Depression Inventory (BDI-II), and Beck Anxiety Inventory (BAI). Chi-square analyses and two-tailed Wilcoxon rank sum tests were used for the analyses. Subjects with interictal photophobia had significantly higher scores on the photophobia questionnaire compared to subjects without interictal photophobia. Subjects with interictal photophobia had significantly higher scores on the BDI-II and BAI compared to subjects without interictal photophobia. Migraine patients with interictal photophobia are more likely to manifest symptoms of depression and anxiety compared to migraine patients without interictal photophobia. Care providers should be aware of increased prevalence of these symptoms in this population and consider appropriate referrals. Future research could assess whether treatment of photophobia leads to improvements in symptoms of depression and anxiety in migraine patients.